Source Paper
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
Guy Griebel, Jacques Simiand, Claudine Serradeil-Le Gal, Jean Wagnon, Marc Pascal et al.
Proceedings of the National Academy of Sciences • 2002
Social Defeat Paradigm
Objective: An atypical anxiety model measuring stress-induced anxiety following social defeat exposure to assess anxiolytic-like effects of test compounds
This is a Social Defeat Paradigm protocol using rodent (rats and mice) as the model organism. The procedure involves 3 procedural steps, 1 equipment items. Extracted from a 2002 paper published in Proceedings of the National Academy of Sciences.
Model and subjects
rodent (rats and mice) • Not specified • unknown • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Social Defeat Exposure • Test Compound Administration • Anxiety Assessment
Primary readouts
- Anxiety-like behavior following social defeat exposure
- Anxiolytic-like activity of test compound
- Stress-induced behavioral changes
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Social Defeat Exposure
Subjects are exposed to social defeat as a stressor to induce anxiety-like behavior
Note: This is an atypical anxiety model involving traumatic stress exposure
View evidence from paper
“social defeat paradigm and the defense test battery (1–30 mg/kg, p.o.)”
Test Compound Administration
SSR149415 administered at specified doses via oral (p.o.) or intraperitoneal (i.p.) routes
Note: Doses ranged from 1-30 mg/kg depending on test model
View evidence from paper
“SSR149415 produced clear-cut anxiolytic-like activity in models involving traumatic stress exposure, such as the social defeat paradigm and the defense test battery (1–30 mg/kg, p.o.)”
Anxiety Assessment
Behavioral measures of anxiety-like responses are recorded following social defeat exposure and compound administration
Note: Specific behavioral measures not detailed in provided text
View evidence from paper
“social defeat-induced anxiety rodent models of anxiety”